Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis

Cancer Metastasis Reviews
Motoharu SeikiIkuo Yana

Abstract

Membrane-type 1 matrix metalloproteinase (MT1-MMP) is an integral membrane proteinase that is frequently expressed in malignant cancer cells and has potent invasion-promoting activity. When expressed on the cell surface, MT1-MMP degrades the extracellular matrix (ECM) barrier adjacent to the cells to maintain the migration route to traverse the tissue. But MT1-MMP is not just an enzyme that degrades ECM. MT1-MMP also introduces limited cleavage into proteins at the cell-ECM interspaces and converts their functions. The target molecules are ECM components, cell adhesion molecules, and latent forms of MMPs. Through these processing events MT1-MMP modulates the migratory and invasive behavior of the cells.

Citations

Nov 10, 2005·The Journal of Pathology·Marisa Parmo-CabañasJoaquin Teixidó
Jan 6, 2007·The Journal of Biological Chemistry·John R BasileJ Silvio Gutkind
Mar 26, 2008·Laboratory Investigation; a Journal of Technical Methods and Pathology·Maria V BarbolinaM Sharon Stack
Mar 31, 2009·American Journal of Respiratory Cell and Molecular Biology·Michael J SchuligaAlastair G Stewart
Oct 26, 2012·The Journal of Biological Chemistry·Vladislav S Golubkov, Alex Y Strongin
Jul 15, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Nadia A HasaneenHussein D Foda
May 9, 2006·Cancer Metastasis Reviews·Alex Y Strongin
Oct 31, 2007·Clinical & Experimental Metastasis·Vincent Chabottaux, Agnès Noel
Jul 8, 2010·The Journal of Biological Chemistry·Surabhi Dangi-GarimellaHidayatullah G Munshi
Oct 13, 2011·Journal of Cellular Physiology·Takayuki UematsuNaohiko Koshikawa
May 4, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Pablo F BarcelonaGustavo A Chiabrando
Oct 24, 2012·The Journal of Cell Biology·Xinzi YuLaura M Machesky
Oct 27, 2017·Cell Death & Disease·Naohiko KoshikawaMotoharu Seiki
Mar 16, 2004·The Journal of Biological Chemistry·Borhane AnnabiRichard Béliveau
Nov 4, 2005·Immunology and Cell Biology·Xun QuLiwei Lu
Jan 21, 2006·International Journal of Cancer. Journal International Du Cancer·Cornelis F M SierArko Gorter
Jun 24, 2008·Journal of Toxicology and Environmental Health. Part a·Masashi KatoYuji Goto
Nov 7, 2006·Clinical & Experimental Metastasis·Ellen E RolloStanley Zucker
Apr 9, 2016·Virchows Archiv : an International Journal of Pathology·Ryoko TatsukawaKazuki Nabeshima
Jul 29, 2011·The Journal of Biological Chemistry·Kevin ZarrabiJian Cao
Mar 4, 2005·Journal of Cellular Physiology·Stephan KusickThomas Ludwig
Dec 23, 2006·Journal of Leukocyte Biology·Helene PiccardGhislain Opdenakker
May 19, 2006·Cancer Research·Vincent ChabottauxAgnès Noël
Sep 17, 2019·Life Sciences·Sajjad Ahmadpour, Seyed Jalal Hosseinimehr
Feb 9, 2011·Biochemical and Biophysical Research Communications·Izumi OnozukaMamoru Watanabe
Mar 23, 2005·Biochimie·N E Sounni, A Noel
Jul 10, 2021·Photodiagnosis and Photodynamic Therapy·Soichiro OgawaEigo Otsuji

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.